MMS Hires CRO Leader Lisa James as Director of Business Operations and Client Relations
Durham, N.C. (June 13, 2018) – MMS Holdings Inc. (MMS) – a leading global clinical research organization – announced today that Lisa James has joined as Director, Business Operations and Client Relations. James brings a depth of industry and business experience, having most recently held the position as Director of Corporate Operations at Health Decisions, Inc.
In this role, James will be responsible for leading business growth initiatives, including lead generation and new client introductions through project award, and the management of all aspects of proposal and budget development. Additionally, James will play a key role in the further development of strategic partnerships in the pharmaceutical industry.
“Lisa is a detailed and metrics-driven leader known for her understanding of key issues in clinical development outsourcing, and MMS is delighted to welcome her to the leadership team,” said Kelly J. Hill, Executive Director, Global Project & Account Management, MMS. “The needs of our clients change every day and Lisa’s expertise and insights are needed to ensure we make timely introductions and bring practical operational and commercial solutions.”
For her leadership, James was recognized by the Triangle Business Journal in 2014 with its 40 Under 40 Leadership Award and in 2015 with its Women in Business Award.
“I am incredibly excited to move into this role at MMS, and plan on making a positive impact within the company and to benefit our clients’ successful development of innovative products that receive marketing approval to address unmet medical needs,” James said. “Working with sponsors directly, helping them find business solutions in the areas of data management, clinical programming and biostatistics, regulatory submissions, medical writing, transparency, and other areas, is something that I very much look forward to.”
James brings deep experience in partnering with biopharma and medical device companies and government organizations to her role at MMS. Prior to joining MMS, James held business operations positions at Health Decisions, Inc. and at Fulcrum Pharma Developments, Inc. which was later acquired by Aptiv Solutions and is now part of ICON plc.
MMS continues to hire key leaders in North Carolina and across the globe.
For open opportunities, visit: mmsholdings careers
Suggested For You
news
November 7th, 2024
MMS Named a Finalist in the 2024 Fierce CRO Awards for Leadership in Regulatory Compliance
news
July 17th, 2024
Industry Veteran Ben Dudley Joins MMS as Chief Commercial Officer (CCO) to Drive Continued Growth for the Data-focused Clinical Research Organization
news
April 4th, 2024
MMS Hires Pharmaceutical Industry Veteran James Zee for Global Biometrics Leadership in Europe Amid Strong Regional Growth
news
March 6th, 2024
MMS Holdings Inc – A Data-Centric CRO Powerhouse Reshaping Drug Development on a Global Scale
news
December 13th, 2023
MMS Supported Lykos Therapeutics: NDA Submitted to FDA for First Psychedelic-Assisted Therapy for PTSD
news
April 18th, 2023
MMS Named Great Place to Work in the UK as Growth in the Region Doubles
news
March 21st, 2023
MMS Scientific Advisory Board’s New Members Expand CRO’s Therapeutic Expertise
news
February 21st, 2023
MMS Partners with I-ACT to Advance Children’s Clinical Trials
news
February 7th, 2023
Award-Winning Data CRO Expands Executive Leadership to Support Company’s Next Stage of Growth
news
January 11th, 2023
MMS Named a Great Place to Work in India
news
November 21st, 2022
MMS Named Michigan Top Workplace For The Second Consecutive Year
news
August 16th, 2022
Together Trial with EDC Database Designed by MMS Wins Trial of the Year